US – France bridge.

We facilitate connections between US-based venture capitalists and French biotech companies and vice – versa. This service is designed to bridge the gap and support efficient development of the industry. Our clients have access to innovation, vast investment offerings and talent opportunities between France and the US, creating exciting growth potential for both sides.

Benefits:

• Introduction to US VCs interested in the French biotech market
• Expanding cross-border investment opportunities
• Building valuable relationships and introductions to accelerate growth

Access to the vast amount to talent available globally